Captrust Financial Advisors »

Travere Therapeutics shares owned by Captrust Financial Advisors

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Captrust Financial Advisors from 13F filings

Historical chart of Captrust Financial Advisors investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Captrust Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Captrust Financial Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $791k 21k 38.21
2025-09-30 $453k 19k 23.90
2023-12-31 $225k 25k 8.99
2023-09-30 $359k 40k 8.94
2023-06-30 $400k 26k 15.36
2022-06-30 $4.0k 168 23.81
2022-03-31 $4.0k 168 23.81
2021-12-31 $5.0k 168 29.76
2021-09-30 $4.0k 168 23.81

More positions owned by Captrust Financial Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Apple Stock (AAPL)
Ishares 1-3 Year Treasury Bond Etf Etf (SHY)
Microsoft Corp Stock (MSFT)
Vanguard Value Etf (VTV)
Nvidia Corporation Stock (NVDA)
Ishares Core Msci Total International Stock Etf Etf (IXUS)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Vanguard S&p 500 Etf Etf (VOO)
Ishares 3-7 Year Treasury Bond Etf Etf (IEI)
Vanguard Small-cap Etf Etf (VB)
Ishares Core Msci Emerging Market Etf Etf (IEMG)
Vanguard Growth Etf Etf (VUG)
Amazon Stock (AMZN)

View all positions for Captrust Financial Advisors

Top funds holding Travere Therapeutics

Henderson Group
FMR
BlackRock
Vanguard Group
Armistice Capital
State Street Corporation
Perceptive Advisors
Vanguard Capital Management
Nomura Asset Management International
Adage Capital Partners GP
Kynam Capital Management
Geode Capital Management
Renaissance Technologies
Stephens Investment Management Group
Goldman Sachs Group

View all funds holding Travere Therapeutics